Stockscreener 앱 받기
0.27
5.53%
-0.0158
시간 외 거래:
.27
전일 마감가:
$0.2858
열려 있는:
$0.2858
하루 거래량:
348.59K
Relative Volume:
1.49
시가총액:
$12.63M
수익:
-
순이익/손실:
$-30.01M
주가수익비율:
-0.2213
EPS:
-1.22
순현금흐름:
$-23.94M
1주 성능:
-12.31%
1개월 성능:
-48.71%
6개월 성능:
-77.12%
1년 성능:
-74.04%
1일 변동 폭
$0.2607
$0.29
1주일 범위
$0.2607
$0.3298
52주 변동 폭
$0.2607
$2.48
인에잇바이오 Stock (INAB) Company Profile
명칭
In 8 Bio Inc
전화
(646) 600-6438
주소
EMPIRE STATE BUILDING, NEW YORK
인에잇바이오 Stock (INAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-30 | 개시 | H.C. Wainwright | Buy |
인에잇바이오 주식(INAB)의 최신 뉴스
Biomarker Data from Oncology Trial for Adicet Bio’s Game Delta T-cell Therapy ADI-001 Indicates Potential for Use in Autoimmune Disease - CGTLive™
bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 - Business Wire
Analysts’ Weekly Ratings Changes for Adicet Bio (ACET) - Defense World
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference - ForexTV.com
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference - StockTitan
8x8 Inc executive sells over $25k in company stock By Investing.com - Investing.com South Africa
8x8 CEO sells over $48k in company stock By Investing.com - Investing.com UK
New insider Divincenzo Jonathan P. claimed no ownership of stock in the company (SEC Form 3) - Quantisnow
SEC Form 424B5 filed by INmune Bio Inc. - Quantisnow
Indian Immunologicals Signs Pact For Clinical Development Of Zika Vaccine - Afternoon Voice
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine - NDTV
Biopharma Layoff Tracker 2024: Biosense Webster, Charles River Laboratories, Vesigen and More Cut Staff - BioSpace
Owning 41% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB), - Simply Wall St
SEC Form 4 filed by EVP, President, LSG Barry James - Quantisnow
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - Quantisnow
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Chairman, President, and CEO Schwartz Norman D covered exercise/tax liability with 5,159 units of Bio-Rad A Common Stock and converted options into 10,477 units of Bio-Rad A Common Stock, increasing direct ownership by 1% to 438,238 units (SEC For - Quantisnow
Director Allison Schwartz converted options into 247 units of Bio-Rad A Common Stock and covered exercise/tax liability with 118 units of Bio-Rad A Common Stock, increasing direct ownership by 11% to 1,305 units (SEC Form 4) - Quantisnow
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis - Business Standard
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference - StockTitan
bluebird bio (BLUE) – Analysts’ Weekly Ratings Updates - Defense World
Director Allison Schwartz received a gift of 57 units of Bio-Rad B Common Stock, increasing direct ownership by 1% to 3,996 units (SEC Form 4) - Quantisnow
Large owner Schwartz Steven D received a gift of 114 units of Bio-Rad B Common Stock, increasing direct ownership by 0.23% to 25,234 units (SEC Form 4) - Quantisnow
Director Emeritus Schwartz Alice N gifted 342 units of Bio-Rad B Common Stock and gifted 3,190 units of Bio-Rad A Common Stock (SEC Form 4) - Quantisnow
Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire
Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Yahoo Finance
bluebird bio Announces Receipt of Expected Notices from Nasdaq - Business Wire
California State Teachers Retirement System Invests $334,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline - Longview News-Journal
Gritstone bio, Inc. Sued for Securities Law ViolationsContact The Rosen Law Firm Before August 6, 2024 to Discuss Your Rights - Longview News-Journal
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update - Quantisnow
bluebird bio, Inc. (NASDAQ:BLUE) Q2 2024 Earnings Call Transcript - Insider Monkey
Investors in bluebird bio, Inc. Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - Longview News-Journal
GRTS Investors Have Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit - Longview News-Journal
Q2 2024 bluebird bio Inc Earnings Call Transcript - GuruFocus.com
bluebird bio Inc (BLUE) Q2 2024 Earnings: EPS Miss, Revenue Falls Short at $16.1 Million - GuruFocus.com
Green and Bio-Based Solvents Market Share Will Reach Over - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Q2 2024 Earnings Call Transcript - Insider Monkey
Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now? - Yahoo Finance UK
TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript - Seeking Alpha
2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call Transcript - Insider Monkey
Vanguard Group Inc. Has $20.94 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
bluebird bio Announces Second Quarter 2024 Results Call Date - Business Wire
Passage Bio, Inc. (NASDAQ:PASG) Forecasted to Post Q3 2024 Earnings of ($0.17) Per Share - Defense World
Wedbush Analysts Reduce Earnings Estimates for Passage Bio, Inc. (NASDAQ:PASG) - Defense World
2seventy bio, Inc. (TSVT) Q2 2024 Earnings Call Transcript - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2024 Earnings Call Transcript - Seeking Alpha
Kronos Bio : Reports Second Quarter 2024 Financial Results and Pipeline Update Form 8 K - Marketscreener.com
Cabaletta Bio Inc (CABA) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Q32 Bio: Q2 Earnings Snapshot - San Francisco Chronicle
인에잇바이오 (INAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
4.86%
자본화:
|
볼륨(24시간):